• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ventyx Biosciences, Inc. - Common Stock (NQ:VTYX)

3.695 -0.015 (-0.40%)
Streaming Delayed Price Updated: 11:22 AM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 96,810
Open 3.630
Bid (Size) 3.690 (4)
Ask (Size) 3.700 (3)
Prev. Close 3.710
Today's Range 3.603 - 3.740
52wk Range 0.7830 - 4.050
Shares Outstanding 58,556,952
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Let's uncover which stocks are experiencing notable gaps during today's session.
October 01, 2025
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
September 22, 2025
 
Via Benzinga

Performance

YTD
+72.7%
+72.7%
1 Month
+60.7%
+60.7%
3 Month
+31.5%
+31.5%
6 Month
+235.9%
+235.9%
1 Year
+57.9%
+57.9%

More News

Read More
12 Health Care Stocks Moving In Friday's After-Market Session
September 05, 2025
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 11, 2025
Via Benzinga
Ventyx (VTYX) Q2 Net Loss Drops 16%
August 07, 2025
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
May 22, 2025
Via Benzinga
Which stocks are gapping on Thursday?
May 22, 2025
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 22, 2025
Via Benzinga
VENTYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ventyx Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
December 10, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
Sanofi Injects $27M In Neurology Drug Developer Ventyx Biosciences
September 23, 2024
Via Benzinga
VTYX Stock Earnings: Ventyx Biosciences Beats EPS for Q2 2024
August 09, 2024
Via InvestorPlace
Dow Edges Lower; Ventyx Biosciences Shares Plummet
July 29, 2024
Via Benzinga
Topics Stocks
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 29, 2024
Via Benzinga
Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump
July 29, 2024
Via Benzinga
Ventyx Biosciences' Inflammatory Bowel Disease Candidate Flunks In Mid-Stage Study, Company Looks For Partner To Pursue It Further
July 29, 2024
Via Benzinga
S&P 500 Edges Lower; J. M. Smucker Shares Surge Following Earnings Beat
June 06, 2024
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Thursday's Intraday Session
June 06, 2024
Via Benzinga
Crude Oil Jumps 2%; Lululemon Posts Upbeat Earnings
June 06, 2024
Via Benzinga
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 06, 2024
Via Benzinga
VENTYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ventyx Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
June 03, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
VTYX Stock Earnings: Ventyx Biosciences Beats EPS for Q1 2024
May 09, 2024
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 08, 2024
Via Benzinga
VTYX DEADLINE TODAY: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
April 30, 2024
Via NewMediaWire
Topics Lawsuit
VTYX DEADLINE TODAY: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
April 30, 2024
Via TheNewswire.com
Topics Lawsuit
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses to Contact the Firm
April 30, 2024
From Schall Law
Via GlobeNewswire

Frequently Asked Questions

Is Ventyx Biosciences, Inc. - Common Stock publicly traded?
Yes, Ventyx Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Ventyx Biosciences, Inc. - Common Stock trade on?
Ventyx Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ventyx Biosciences, Inc. - Common Stock?
The ticker symbol for Ventyx Biosciences, Inc. - Common Stock is VTYX on the Nasdaq Stock Market
What is the current price of Ventyx Biosciences, Inc. - Common Stock?
The current price of Ventyx Biosciences, Inc. - Common Stock is 3.695
When was Ventyx Biosciences, Inc. - Common Stock last traded?
The last trade of Ventyx Biosciences, Inc. - Common Stock was at 10/14/25 11:22 AM ET
What is the market capitalization of Ventyx Biosciences, Inc. - Common Stock?
The market capitalization of Ventyx Biosciences, Inc. - Common Stock is 216.37M
How many shares of Ventyx Biosciences, Inc. - Common Stock are outstanding?
Ventyx Biosciences, Inc. - Common Stock has 216M shares outstanding.
Recent Quotes
View More
Symbol Price Change (%)
GOOG  246.27
+1.63 (0.67%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap